GC Therapeutics (Copy)
Biotechnology · Cell & Gene Therapy
Overview
Discover GC Therapeutics, a pioneer in scalable, cutting-edge cell therapies designed to revolutionize treatment across a broad range of therapeutic areas.
Funding and backers
Backers
3
Andreessen Horowitz, Global Brain
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 2019
Website went live first capture in the Wayback Machine
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Next-generation CAR T-cell therapies engineered to disrupt the tumor microenvironment OUR MISSION CARTemis Therapeutics is a clinical-stage…
Designer cell therapies for pets first and their people next.
MediSix Therapeutics develops innovative T-cell therapies using its proprietary PEBL technology platform. An IASO Biotechnology subsidiary.
Pioneering Cell Therapies for the Central Nervous System. We are a Salt Lake City-based biotechnology company developing novel macrophage…
Anocca is creating a pipeline of precision T-cell immunotherapies by combining its novel approach to T-cell biology, cutting-edge…
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Mubadala VenturesVia a fund
Global BrainVia a fund
535 portfolio companies
Andreessen HorowitzVia a fund
857 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors